AUTHOREA
Log in Sign Up Browse Preprints

December 20, 2022
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardl...
Ian Pavord, Arnaud Bourdin, Alberto Papi, et al.
October 13, 2022
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma...
David Price, paul pfeffer, Nasloon Ali, et al.